Antibacterial therapy and newer agents:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia, Pa.
Saunders
2011
|
| Schriftenreihe: | Medical clinics of North America
95,4 |
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index Preface: Antibacterial therapy and newer agents / Keith S. Kaye and Donald Kaye -- Pathogens resistant to antibacterial agents / Luke F. Chen, Teena Chopra, and Keith S. Kaye -- Use of antibacterial agents in renal failure / Brett Gilbert, Paul Robbins, and Lawrence L. Livornese, Jr. -- Topical antibacterial agents / Peter A. Lio and Elaine T. Kaye -- Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftaroline / Michael D. Nailor and Jack D. Sobel -- Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime / Jose A. Bazan, Stanley I. Martin, and Kenneth M. Kaye -- Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline) / Jerry M. Zuckerman, Fozia Qamar, and Bartholomew R. Bono -- The newer fluoroquinolones / Maureen K. Bolon -- Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides / Luke F. Chen and Donald Kaye |
| Beschreibung: | XII S., S. 647 - 854 Ill. 24 cm |
| ISBN: | 9781455722914 145572291X |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV039529813 | ||
| 003 | DE-604 | ||
| 005 | 20150202 | ||
| 007 | t | ||
| 008 | 110816s2011 a||| |||| 00||| eng d | ||
| 020 | |a 9781455722914 |9 978-1-4557-2291-4 | ||
| 020 | |a 145572291X |9 1-4557-2291-X | ||
| 035 | |a (OCoLC)727710215 | ||
| 035 | |a (DE-599)BVBBV039529813 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 245 | 1 | 0 | |a Antibacterial therapy and newer agents |c guest ed. Keith S. Kaye ; Donald Kaye |
| 264 | 1 | |a Philadelphia, Pa. |b Saunders |c 2011 | |
| 300 | |a XII S., S. 647 - 854 |b Ill. |c 24 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Medical clinics of North America |v 95,4 | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Preface: Antibacterial therapy and newer agents / Keith S. Kaye and Donald Kaye -- Pathogens resistant to antibacterial agents / Luke F. Chen, Teena Chopra, and Keith S. Kaye -- Use of antibacterial agents in renal failure / Brett Gilbert, Paul Robbins, and Lawrence L. Livornese, Jr. -- Topical antibacterial agents / Peter A. Lio and Elaine T. Kaye -- Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftaroline / Michael D. Nailor and Jack D. Sobel -- Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime / Jose A. Bazan, Stanley I. Martin, and Kenneth M. Kaye -- Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline) / Jerry M. Zuckerman, Fozia Qamar, and Bartholomew R. Bono -- The newer fluoroquinolones / Maureen K. Bolon -- Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides / Luke F. Chen and Donald Kaye | ||
| 650 | 4 | |a Antibacterial agents | |
| 650 | 4 | |a Anti-infective agents | |
| 650 | 4 | |a Bacterial diseases / Treatment | |
| 700 | 1 | |a Kaye, Keith S. |e Sonstige |0 (DE-588)140155066 |4 oth | |
| 830 | 0 | |a Medical clinics of North America |v 95,4 |w (DE-604)BV000003310 |9 95,4 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024382119 | ||
Datensatz im Suchindex
| _version_ | 1804148341455454208 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)140155066 |
| building | Verbundindex |
| bvnumber | BV039529813 |
| ctrlnum | (OCoLC)727710215 (DE-599)BVBBV039529813 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02179nam a2200349 cb4500</leader><controlfield tag="001">BV039529813</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150202 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110816s2011 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781455722914</subfield><subfield code="9">978-1-4557-2291-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">145572291X</subfield><subfield code="9">1-4557-2291-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)727710215</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV039529813</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibacterial therapy and newer agents</subfield><subfield code="c">guest ed. Keith S. Kaye ; Donald Kaye</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia, Pa.</subfield><subfield code="b">Saunders</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII S., S. 647 - 854</subfield><subfield code="b">Ill.</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Medical clinics of North America</subfield><subfield code="v">95,4</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Preface: Antibacterial therapy and newer agents / Keith S. Kaye and Donald Kaye -- Pathogens resistant to antibacterial agents / Luke F. Chen, Teena Chopra, and Keith S. Kaye -- Use of antibacterial agents in renal failure / Brett Gilbert, Paul Robbins, and Lawrence L. Livornese, Jr. -- Topical antibacterial agents / Peter A. Lio and Elaine T. Kaye -- Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftaroline / Michael D. Nailor and Jack D. Sobel -- Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime / Jose A. Bazan, Stanley I. Martin, and Kenneth M. Kaye -- Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline) / Jerry M. Zuckerman, Fozia Qamar, and Bartholomew R. Bono -- The newer fluoroquinolones / Maureen K. Bolon -- Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides / Luke F. Chen and Donald Kaye</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibacterial agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-infective agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bacterial diseases / Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaye, Keith S.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)140155066</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Medical clinics of North America</subfield><subfield code="v">95,4</subfield><subfield code="w">(DE-604)BV000003310</subfield><subfield code="9">95,4</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024382119</subfield></datafield></record></collection> |
| id | DE-604.BV039529813 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T00:05:36Z |
| institution | BVB |
| isbn | 9781455722914 145572291X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024382119 |
| oclc_num | 727710215 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | XII S., S. 647 - 854 Ill. 24 cm |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Saunders |
| record_format | marc |
| series | Medical clinics of North America |
| series2 | Medical clinics of North America |
| spelling | Antibacterial therapy and newer agents guest ed. Keith S. Kaye ; Donald Kaye Philadelphia, Pa. Saunders 2011 XII S., S. 647 - 854 Ill. 24 cm txt rdacontent n rdamedia nc rdacarrier Medical clinics of North America 95,4 Includes bibliographical references and index Preface: Antibacterial therapy and newer agents / Keith S. Kaye and Donald Kaye -- Pathogens resistant to antibacterial agents / Luke F. Chen, Teena Chopra, and Keith S. Kaye -- Use of antibacterial agents in renal failure / Brett Gilbert, Paul Robbins, and Lawrence L. Livornese, Jr. -- Topical antibacterial agents / Peter A. Lio and Elaine T. Kaye -- Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftaroline / Michael D. Nailor and Jack D. Sobel -- Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime / Jose A. Bazan, Stanley I. Martin, and Kenneth M. Kaye -- Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline) / Jerry M. Zuckerman, Fozia Qamar, and Bartholomew R. Bono -- The newer fluoroquinolones / Maureen K. Bolon -- Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides / Luke F. Chen and Donald Kaye Antibacterial agents Anti-infective agents Bacterial diseases / Treatment Kaye, Keith S. Sonstige (DE-588)140155066 oth Medical clinics of North America 95,4 (DE-604)BV000003310 95,4 |
| spellingShingle | Antibacterial therapy and newer agents Medical clinics of North America Antibacterial agents Anti-infective agents Bacterial diseases / Treatment |
| title | Antibacterial therapy and newer agents |
| title_auth | Antibacterial therapy and newer agents |
| title_exact_search | Antibacterial therapy and newer agents |
| title_full | Antibacterial therapy and newer agents guest ed. Keith S. Kaye ; Donald Kaye |
| title_fullStr | Antibacterial therapy and newer agents guest ed. Keith S. Kaye ; Donald Kaye |
| title_full_unstemmed | Antibacterial therapy and newer agents guest ed. Keith S. Kaye ; Donald Kaye |
| title_short | Antibacterial therapy and newer agents |
| title_sort | antibacterial therapy and newer agents |
| topic | Antibacterial agents Anti-infective agents Bacterial diseases / Treatment |
| topic_facet | Antibacterial agents Anti-infective agents Bacterial diseases / Treatment |
| volume_link | (DE-604)BV000003310 |
| work_keys_str_mv | AT kayekeiths antibacterialtherapyandneweragents |